Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 12

Results: 14

Predict the Drug–Drug Interaction of a Novel PI3Kα/δ Inhibitor, TQ‐B3525, and Its Two Metabolites Using Physiologically Based Pharmacokinetic Modeling.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1517, doi. 10.1002/jcph.6111

By:

Zhu, Shixing;
Yu, Ding;
Wang, Xunqiang;
Wang, Xin

Publication type:

Article

Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1594, doi. 10.1002/jcph.6116

By:

Eales, Brianna;
Helal, Nada A.;
Vattelana, Olivia;
Kronfol, Mohamad M.;
Fletcher, Elimika Pfuma;
Wang, Yow‐Ming;
Burckart, Gilbert J.;
Vaidyanathan, Jayabharathi;
Seo, Shirley K.;
Nounou, Mohamed Ismail

Publication type:

Article

Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non‐Japanese Participants.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1586, doi. 10.1002/jcph.6114

By:

Younis, Islam R.;
Nelson, Cara;
Weber, Elijah J.;
Shen, Gong;
Qin, Ann R.;
Xiao, Deqing;
Watkins, Timothy R.;
Othman, Ahmed A.

Publication type:

Article

Tracing the Evolution: A Comprehensive Bibliometric Analysis of Drug Interaction Clinical Studies.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1505, doi. 10.1002/jcph.6112

By:

Li, Lanping;
Zhou, Yushi;
Ye, Lika;
Xie, Zhihong

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of Pathophysiological Changes in Neonates: Strengths, Weaknesses, and Next Steps.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1606, doi. 10.1002/jcph.6148

By:

Allegaert, Karel

Publication type:

Article

Redefining Statin Dosage Post‐Gastric Bypass: Insights from a Population Pharmacokinetics–Pharmacodynamics Link Approach.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1473, doi. 10.1002/jcph.6110

By:

Conchon Costa, Ana Carolina;
Medeiros, Jose Ivan Marques;
Kang, Wonho;
Yamamoto, Priscila A.;
de Gaitani, Cristiane M.;
Vasconcelos, Mayrla E. D.;
Da Silva, Rodrigo Moreira;
Kemp, Rafael;
Sankarankutty, Ajith K.;
Salgado Jr, Wilson;
Santos, Jose Sebastiao;
Schmidt, Stephan;
De Moraes, Natalia Valadares

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1467, doi. 10.1002/jcph.2086
Publication type:: Article

Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1576, doi. 10.1002/jcph.6113

By:

Hu, Xiaotong;
Lin, Hongda;
Huang, Yan;
Xu, Pingsheng;
Xu, Bin;
Yu, Haibin;
Wang, Meixia;
Feng, Sheng;
Li, Yijing;
Shen, Kai

Publication type:

Article

Driving Efficiency: Leveraging Model‐Informed Approaches in 505(b)(2) Regulatory Actions.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1484, doi. 10.1002/jcph.6109

By:

Sharma, Vishnu Dutt;
Bhattaram, Venkatesh Atul;
Krudys, Kevin;
Li, Zhihua;
Marathe, Anshu;
Mehrotra, Nitin;
Wang, Xiaofeng;
Liu, Jiang;
Stier, Ethan;
Florian, Jeffry;
Madabushi, Raj;
Zhu, Hao

Publication type:

Article

Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1541, doi. 10.1002/jcph.6104

By:

Nomoto, Maiko;
Hasunuma, Tomoko;
Cai, Cuiyuan;
Suzuki, Ippei;
Mikubo, Ayano;
Funasaka, Setsuo;
Otake, Yohei;
Nakai, Kenya;
Yasuda, Sanae

Publication type:

Article

Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1528, doi. 10.1002/jcph.6105

By:

Martha, Srinivas;
Jangam, Preethi Hepzibah;
Bhansali, Suraj G.

Publication type:

Article

Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1491, doi. 10.1002/jcph.6108

By:

Wen, Jiali;
McCann, Sean;
Balevic, Stephen J.;
Muller, William J.;
Hornik, Chi D.;
Autmizguine, Julie;
Anderson, Sarah G.;
Payne, Elizabeth H.;
Turdalieva, Sitora;
Gonzalez, Daniel;
Benjamin, Daniel K.;
Zimmerman, Kanecia;
Kennel, Phyllis;
Alderman, Cheryl;
Sund, Zoe;
Opel, Kylie;
Beci, Rose;
Hornik, Chi Dang;
Kearns, Gregory L.;
Laughon, Matthew

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling of Vancomycin in Critically Ill Neonates: Assessing the Impact of Pathophysiological Changes.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1552, doi. 10.1002/jcph.6107

By:

Shuai, Weiwei;
Cao, Jing;
Qian, Miao;
Tang, Zhe

Publication type:

Article

Multiple‐dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 12, p. 1566, doi. 10.1002/jcph.6106

By:

Mueller, Markus S.;
Juif, Pierre‐Eric;
Charfi, Hakim;
Dingemanse, Jasper

Publication type:

Article